Under the arrangement, GSK will have access to Aureus' GPCR, ion channel, kinase, hERG, and ADME/drug-drug interactions databases.
Financial terms of the deal were not disclosed.
Under the arrangement, GSK will have access to Aureus' GPCR, ion channel, kinase, hERG, and ADME/drug-drug interactions databases.
Financial terms of the deal were not disclosed.